Proton Therapy
Proton therapy is a form of particle therapy utilized in the treatment of
cancer, employing a beam of protons to irradiate diseased tissue. Its
primary advantage lies in its ability to precisely target the radiation
dosage compared to other forms of external beam radiotherapy.
During proton therapy, a particle accelerator directs a beam of protons to
target the tumor. These charged particles damage the DNA of cells,
ultimately leading to cell death or interference with their ability to
replicate. Cancer cells, with their heightened rate of division and impaired
DNA repair mechanisms, are particularly susceptible to this type of attack.
Due to their substantial mass, protons exhibit minimal lateral scattering in
tissue, maintaining focus on the tumor and minimizing radiation exposure to
surrounding tissues. Each proton has a designated range within tissue, with
few protons penetrating beyond that distance. Moreover, the maximum dose is
delivered just beyond the tumor's boundary, known as the Bragg peak.
To treat deeper tumors, the proton accelerator must produce a beam with
higher energy, typically measured in electron volts (eV). Tumors closer to
the body's surface are treated with lower-energy protons. Accelerators
typically generate protons with energies ranging from 70 to 250 Mega
electron Volts (MeV). By adjusting proton energy during treatment, cell
damage is maximized within the tumor while minimizing radiation exposure to
nearby tissues. Tissues deeper within the body receive minimal radiation
exposure due to the limited penetration of protons.
Treatment typically involves applying protons of varying energies to cover
the entire tumor, with each energy level corresponding to a specific depth
(illustrated by blue lines). The cumulative radiation dosage is referred to
as the Spread-Out Bragg Peak (SOBP), depicted as a red line. It's crucial to
note that tissues behind or deeper than the tumor receive no radiation from
proton therapy, while those in front or shallower than the tumor receive
radiation based on the SOBP.
Proton therapy finds applications in two main categories of treatments.
Firstly, it's used in diseases requiring higher radiation doses for optimal
efficacy, leading to improved local control. Examples include uveal
melanoma, skull base tumors, and sarcomas. Secondly, it's employed to
minimize side effects by precisely targeting tumors, particularly in
pediatric neoplasms and prostate cancer.
While the effectiveness of proton therapy in prostate cancer treatment
remains debated, its usage continues to grow, especially considering the
high prevalence of prostate cancer diagnoses. Additionally, proton therapy
offers advantages in treating ocular tumors, where its low energy
requirement allows for sophisticated alignment methods to protect sensitive
tissues like the optic nerve and preserve vision.
folder_open Medical Procedures